Profiles for companies starting with 'q'
✉ Email this page to a colleague
Drugs and US Patents for q
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Quagen | METHYLPHENIDATE HYDROCHLORIDE | methylphenidate hydrochloride | SOLUTION;ORAL | 213567-001 | Jun 4, 2020 | AA | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Quagen | FLUVOXAMINE MALEATE | fluvoxamine maleate | TABLET;ORAL | 075889-003 | Nov 29, 2000 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Qilu Antibiotics | CEFEPIME HYDROCHLORIDE | cefepime hydrochloride | INJECTABLE;INJECTION | 203704-001 | Feb 1, 2016 | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | |||||
| Qilu | LENALIDOMIDE | lenalidomide | CAPSULE;ORAL | 217265-004 | Feb 22, 2024 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
